Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovering new genetic and psychosocial pathways in Major Depressive Disorder: the NewMood project.

Psychiatria Danubina - 1 Sept 2011

Freeborough Annabel, Kimpton Jessica

Abstract excerpt

The World Health Organisation predicts that Major Depressive Disorder (MDD) will be the second greatest contributor to the global burden of disease by 2020, however, the neurobiological mechanisms behind the disease and the risk factors for it are yet unknown. NewMood (New Molecules for Mood Disorders) was a research project funded by the EU, collaborating work from 10 European countries with the aim of finding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Depressive Disorder, Major
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Hydrocortisone

Share to Polymorphism, Single Nucleotide

Share to Stress, Psychological

Share to United Kingdom

Source

Identifiers

PMID: 21894122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovering new genetic and psychosocial pathways in Major Depressive Disorder: the NewMood project.PMID 21894122Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Epilogue: Lessons from the CONVERGE study of major depressive disorder in China.Semantic proximity Read ↗

Dysregulation of brain dopamine systems in major depressive disorderSemantic proximity Read ↗

Advances in biomarkers of major depressive disorder.Semantic proximity Read ↗

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorderSemantic proximity Read ↗

The genetics of major depression: moving beyond the monoamine hypothesis.Semantic proximity Read ↗

The neurobiology of depression: inroads to treatment and new drug discovery.Semantic proximity Read ↗

Causes and consequences of major depressive disorder: An encompassing Mendelian randomization studySemantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant responseSemantic proximity Read ↗

Novel therapeutic targets for major depressive disorder related to oxidative stress identified by integrative multi-omics and multi-trait studySemantic proximity Read ↗

Overview of the genetics of major depressive disorder.Semantic proximity Read ↗

Exome-wide screening identifies novel rare risk variants for major depression disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.